Nomic Bio Inc

Website
5333 Avenue Casgrain
Montréal, QC H2T 1X3
https://www.nomic.bio

Nomic Bio Inc, based in Montréal, QC, is pioneering affordable and high-fidelity proteomics solutions through its innovative Omni 1000 platform, which quantifies 1,000 of the most informative proteins for diverse scientific applications. The company is focused on democratizing access to proteomics, providing end-to-end services that include rapid turnaround times and customizable protein panels tailored to specific research needs.

With their cutting-edge nELISA technology, Nomic Bio enables true multiplexing at scale, boasting impressive metrics such as high sensitivity and unrivaled specificity. The platform is recognized for its robust analysis tools and exceptional support, earning praise from leading researchers in the field for its transformative impact on scientific discovery.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Thryv Therapeutics Inc

Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.
Feathers and feather products, Drugs and drug proprietaries

Theratechnologies Inc

Theratechnologies Inc. is a biopharmaceutical company based in Montréal, Quebec, dedicated to the development and commercialization of innovative therapies, primarily for individuals living with HIV. The company currently markets two prescription products, Trogarzo and EGRIFTASV, in the United States and is focused on addressing unmet medical needs in both HIV and oncology. In addition to its marketed products, Theratechnologies is advancing its pipeline, which includes the F8 formulation of tesamorelin for HIV-associated lipodystrophy and ongoing clinical trials utilizing its proprietary SORT1 Technology in oncology. The company aims to make a significant impact on patient lives through its commitment to health innovation. Generated from the website

Inversago Pharma Inc

Inversago Pharma Inc. is a biopharmaceutical company based in Montréal, Canada, focused on developing innovative treatments for patients suffering from metabolic and fibrotic diseases. The company is at the forefront of developing therapies that target the inhibition of peripheral CB1 receptors to alleviate complications associated with metabolic disorders. The company's primary program, INV202, is currently undergoing Phase 2 studies for treating diabetes and associated conditions. Inversago Pharma aims to advance its pipeline of CB1 receptor inhibitors to improve the quality of life for patients affected by various metabolic diseases, including type 1 and type 2 diabetes, non-alcoholic fatty liver disease, and fibrotic diseases. Generated from the website
Canada›Quebec›Nomic Bio Inc

Partial Data by Infogroup (c) 2025. All rights reserved.